BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 22850752)

  • 1. Cancer prevention by targeting angiogenesis.
    Albini A; Tosetti F; Li VW; Noonan DM; Li WW
    Nat Rev Clin Oncol; 2012 Sep; 9(9):498-509. PubMed ID: 22850752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.
    Sogno I; Venè R; Sapienza C; Ferrari N; Tosetti F; Albini A
    Recent Results Cancer Res; 2009; 181():71-6. PubMed ID: 19213559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
    Tosetti F; Ferrari N; De Flora S; Albini A
    FASEB J; 2002 Jan; 16(1):2-14. PubMed ID: 11772931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies.
    Sogno I; Venè R; Ferrari N; De Censi A; Imperatori A; Noonan DM; Tosetti F; Albini A
    Crit Rev Oncol Hematol; 2010 Jul; 75(1):2-14. PubMed ID: 20034809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
    Gronich N; Rennert G
    Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mediterranean Diet, a Rich Source of Angiopreventive Compounds in Cancer.
    Martínez-Poveda B; Torres-Vargas JA; Ocaña MDC; García-Caballero M; Medina MÁ; Quesada AR
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31480406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer: Past, present, and future.
    Umezawa S; Higurashi T; Komiya Y; Arimoto J; Horita N; Kaneko T; Iwasaki M; Nakagama H; Nakajima A
    Cancer Sci; 2019 Oct; 110(10):3018-3026. PubMed ID: 31361372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.
    D'Uva G; Baci D; Albini A; Noonan DM
    Cancer Treat Rev; 2018 Feb; 63():1-18. PubMed ID: 29197745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAIDs and chemoprevention.
    Rao CV; Reddy BS
    Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor inflammatory angiogenesis and its chemoprevention.
    Albini A; Tosetti F; Benelli R; Noonan DM
    Cancer Res; 2005 Dec; 65(23):10637-41. PubMed ID: 16322203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and intervention trials for colorectal cancer.
    Komiya M; Fujii G; Takahashi M; Iigo M; Mutoh M
    Jpn J Clin Oncol; 2013 Jul; 43(7):685-94. PubMed ID: 23613189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives.
    Bisacchi D; Benelli R; Vanzetto C; Ferrari N; Tosetti F; Albini A
    Cancer Detect Prev; 2003; 27(3):229-38. PubMed ID: 12787731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
    Thun MJ; Henley SJ; Patrono C
    J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis and cancer prevention: a vision.
    Noonan DM; Benelli R; Albini A
    Recent Results Cancer Res; 2007; 174():219-24. PubMed ID: 17302199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives.
    Mohammed A; Yarla NS; Madka V; Rao CV
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
    Ramos S
    Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder Cancer Chemopreventive Agents: Current Knowledge and Concepts.
    Khajeh NR; Khoyilar C; Wu Y; Spradling K; Zi X; Youssef RF
    Mini Rev Med Chem; 2018; 18(13):1143-1150. PubMed ID: 26975668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.
    Sehdev A; O'Neil BH
    Curr Treat Options Oncol; 2015 Sep; 16(9):43. PubMed ID: 26187794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.